Sy Jennifer has filed 5 insider transactions across 1 company since August 2024.
Most recent transaction: a grant/award of 575000 shares of AEON Biopharma, Inc. ($AEON) on February 17, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | AEON Biopharma, Inc. | $AEON | Sy Jennifer | PRINCIPAL ACCOUNTING OFFICER | A | Class A Common Stock | 575000 | $0.00 | 575,251.0000 | 11,634,946 | 9999.99% | 4.94% |
| March 4, 2026 | AEON Biopharma, Inc. | $AEON | Sy Jennifer | PRINCIPAL ACCOUNTING OFFICER | A | Class A Common Stock | 925925 | $0.00 | 1,501,176.0000 | 11,634,946 | 160.96% | 7.96% |
| May 21, 2025 | AEON Biopharma, Inc. | $AEON | Sy Jennifer | Chief Accounting Officer | A | Restricted Stock Units | 925925 | $0.00 | 925,925.0000 | 3,984,876 | 9999.99% | 23.24% |
| Aug. 31, 2024 | AEON Biopharma, Inc. | $AEON | Sy Jennifer | PRINCIPAL ACCOUNTING OFFICER | A | Class A Common Stock | 18010 | $0.00 | 18,010.0000 | 539,840 | 9999.99% | 3.34% |
| Aug. 31, 2024 | AEON Biopharma, Inc. | $AEON | Sy Jennifer | PRINCIPAL ACCOUNTING OFFICER | A | Stock Option | 48063 | $0.00 | 48,063.0000 | 539,840 | 9999.99% | 8.90% |